
Cardiovascular diseases included the diseases of heart and vessels and classified into primary and secondary diseases. In those, the secondary cardiovascular diseases included the ischemic heart disease, heart failure, coronary heart disease, myocardial disease, hypertensive heart disease, heart valve disease, and cardiac arrhythmia.
In particular, ischemic heart diseases developed by the out of balances among the supply of blood contents in the coronary arteries which carried the nutrients and oxygen, and the oxygen demands of myocardium.
In general, the causes of cardiovascular diseases are atherosclerosis and hypertension, however, they are developed by another various reasons.
In other words, atherosclerosis could be advanced by the factors of elderly, smoking, diabetes, hypercholesterolemia, and drinking which caused the damages of endothelium and acutely formed the thrombosis.
When these thrombi blocked the coronary arteries by more than 70%, myocardial infarction, the death of a portion of myocardium, developed. If not died, by preventing the blood from moving freely, angina developed and caused the severe chest pains.
Current treatment for the acute myocardial infarction is generally performed by the perfusion therapy such as surgery which largely based on the pharmacological methods, however, it can be said that these therapies are effective only when the ischemic injuries just begin (Hochman and Choo, 1987).
It is reported that the heart failure is occur in more than 40% of patients if the remodeling is delayed after the ischemic injury (Sutton and Sharpe, 2000).
In addition, the rapid inflow of oxygen-rich blood into the tissue results in a very harmful effect, so even after the treatment, secondary damage to the myocardium may occur due to the reperfusion, and this is called reperfusion injury (Cave and Garlick, 2000; Flaherty and Zweier, 1991).
Various therapies have been studied to protect the heart injuries from the ischemia-reperfusion during the past few decades and through these studies the decisive molecular mechanisms that can protect the myocardium have been revealed (Zhao et al., 2003).
According to the statistics of World Health Organization in 2008, among the top 10 major causes of death, the ischemic heart disease was 16% taking the first place in mortality (Lloyd-Jones et al., 2010).
According to the data of Statistics Korea in 2009, heart disease has been ranked the third leading cause of death over the past 10 years and is steadily increasing.
Recently, research on the prevention or treatment of cardiovascular diseases has been actively performed, and many studies have been taken out on drug development that is more effective and stable.
Ischemic reperfusion promotes the formation of reactive oxygen species (ROS) and is closely related to the formation of lipid peroxidation, protein oxidation, and DNA cleavage (Powers et al., 2002; Tacar et al., 2013).
Poly ADP ribose polymerase (PARP) is a kind of nucleic acid polymerase that is abundant in the nucleus. Its activity is caused by single-stranded DNA cleavage and can be induced by the various free radicals.
That is, PARP is rapidly activated by DNA damage, the intracellular nicotinamide adenine dinucleotide (NAD) is consumed to synthesize polymer of ADP-ribose (PAR) at the damaged site, and extensive DNA damage leads to the depletion of NAD.
The depletion of NAD dramatically decreases the intracellular ATP levels, and thus the excessive activity of PARP reduces the ability of cells to generate energy in the form of ATP, eventually leading to apoptosis (Ha and Snyder, 1999; Pieper et al., 2000).
Consequently, inhibition of PARP may enhance the recovery of various cells from oxidative injuries (Thiemermann et al., 1997).
The new PARP inhibitor, INH2BP, has been developed for antiviral or anti-cancer therapy (Endres et al., 1998; Szabo et al., 1997), however, the recent studies have been shown that INH2BP inhibited the oxidant-induced injuries of endothelial cells, and have an excellent prophylactic effect on cell damage in the inflamed animal cells (Franson et al., 1991; Szabo, 1996).
Therefore, this study was undertaken to know the preventive effect of INH2BP on the apoptosis of the rat heart-derived H9c2 cells which were induced the oxidative stress using hydrogen peroxide.
INH2BP was purchased from Sigma-Aldrich (St. Louis, Mo, USA) and dissolved in 0.05% dimethyl sulfoxide (Sigma-Aldrich, St. Louis, Mo, USA), and further diluted in Dulbeccós modified Eaglés media (DMEM) (Thermo Fisher Scientific, Health, USA) without fetal bovine serum (FBS).
Reagents for cell culture, all antibodies and H2O2, and general reagents were purchased from Thermo Fisher Scientific, Cell Signaling Technology Inc. (Beverly, Mass, USA), and Sigma-Aldrich, respectively.
H9c2 cells were purchased from the American Type Culture Collection (Rockville, Md, USA).
H9c2 cells were cultured in DMEM with 10% FBS and 1% penicillin/streptomycin at 37℃ under 95% Air/5% CO2 conditions.
In order to evaluate the viability, H9C2 cells were seeded in 12-well plate to 1 × 104 cells/well and cultured in DMEM for 24 hours at 37℃. After pretreatment in the different concentrations (10~250 μmol/L) of INH2BP for 1 hour, the cells were cultured for 6 hours with 700 μmol/L of H2O2.
Then, the viabilities were analyzed using an optical microscope (Olympus Inc, Tokyo, Japan) connected to a platelet measuring device and a digital camera.
In addition, H9c2 cells were seeded in 96-well plates at a concentration of 1 × 104 cells/well and pretreated at the different concentrations of INH2BP (10~250 μmol/L) for 1 hour. The cells were cultured for 6 hours with the addition of 700 μmol/L of H2O2 and 50 μL of XTT (2,3-bis [2,3-bis [2-methyloxy-4-nitro-5-sulphenfoyl]-2H-tetrazolium-5-carboxanilide) (Biological Industries Co. Beit Haemek, Israel) solution in each well.
To analyze the cell viabilities, the absorbance was measured at 460 nm using a microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, USA) after 2 hours of cultivation at 37℃ (Nowak et al., 2018).
Apoptotic myocardial cells were qualitatively analyzed using Hoechst 33342 staining method (BD Biosciences, Franklin Lakes, NJ, USA) which distinguishes between normal and apoptotic cells based on the condensation and the fragmentation of nuclear chromatin (Crowley et al., 2016).
H9c2 cells were seeded in 8-well chamber slides at a concentration of 1 × 104 cells/well and incubated in DMEM at 37℃ for 24 hours. The cells were pretreated at different concentrations of INH2BP (10~250 μmol/L) for 1 hour, and then incubated for 6 hours with 700 μmol/L of H2O2.
After that, the cells were stained with 2 μg/mL of Hoechst 33342 for 15 minutes and washed with phosphate buffered saline (PBS) twice and then observed under a fluorescence microscope (FV-1000, Olympus, Tokyo, Japan).
Using a green fluorescent probe, 6-carboxy-2',7'-dichlorofluoroscein diacetate (DCF-DA; Invitrogen, Rockville, MD, USA), the production of the intracellular ROS was analyzed (Pogue et al., 2012).
First, H9c2 cells were dispensed on 8-well cell culture plates (SPL, Seoul, Korea) at a concentration to 1 × 104 cells/well and cultivated in DMEM at 37℃ for 24 hours. The cells were further cultured for 6 hours with 700 μmol /L H2O2 after the pretreatment with a different concentration of INH2BP (10~250 μmol/L).
Subsequently, they were stained with 10 μmol/L of DCF-DA for 30 minutes at 37℃ and observed under a fluorescence microscope system (FV-1000 spectral, Olympus, Tokyo, Japan).
In addition, H9c2 cells were aliquoted into black-welled 96-well plates to 1 × 104 cells/well, and stained with 10 μmol /L of DCF-DA at 37℃ for 30 minutes. ROS was measured using a fluorescence photometer (Victor 3, Perkin Elmer, Waltham, MA, USA excitation = 485 nm) according to the fluorescence measurement method.
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity: DPPH radical scavenging activity was measured as described by Nanjo et al. (Chen et al., 2001; Nanjo et al., 1996). Briefly, 60 μL of 1 mM INH2BP was added to 60 μL of DPPH (St. Louis, Mo, USA) (60 mM) in a methanol solution. After the solution was mixed vigorously for 10 sec, it was transferred into a 100 μL Teflon capillary tube, and the scavenging activity of INH2BP, with regard to DPPH radicals, was measured using an ESR spectrometer. The spin adduct was measured by the ESR spectrometer exactly 2 min later. The experimental conditions were as follows; central field, 3,475 G; modulation frequency, 100 kHz; modulation amplitude, 2 G; microwave power, 5 mW; gain, 6.3 × 105; and temperature, 298 K.
Superoxide radical scavenging activity: Superoxide radicals were generated as a result of the ultraviolet irradiation of a riboflavin/ethlylenediaminetetraacetic acid solution. The reaction mixtures that contained 0.1 mL of 0.8 mM riboflavin, 0.1 mL of 1.6 mL EDTA, 0.1 mL of 800 mL DMPO, and 1 mL of 1 mM INH2BP were irradiated for 1 min under an ultraviolet lamp at 365 nm. The measurement conditions were as follows; central field, 3,475 G; modulation frequency, 100 kHz; modulation amplitude, 2 G; microwave power, 1 mW; gain, 6.3 × 105; and temperature, 298 K.
Hydroxyl radical scavenging activity: Hydroxyl radicals were generated by an iron-catalyzed Haber-Weiss reaction (i.e., a Fenton-driven Haber-Weiss reaction), and the generated hydroxyl radicals rapidly reacted with nitrone spin-trap DMPO. The resultant DMPO-OH adduct was detected using an ESR spectrometer. Briefly, 0.2 mL of 1 mM INH2BP was mixed with 0.2 mL of DMPO (0.3 M), 0.2 mL of FeSO4 (10 mM), and 0.2 mL of H2O2 (10 mM) in a phosphate buffer solution (pH 7.2), and the resulting solution was transferred into a 100 μL Teflon capillary tube. After 2.5 min, the ESR spectrum was recorded on a JES-FA ESR spectrometer (JEOL Ltd., Tokyo, Japan). The experimental conditions were as follows; central field, 3,475 G; modulation frequency, 100 kHz; modulation amplitude, 2 G; microwave power, 1 mW; gain, 6.3 × 105; and temperature, 298 K.
Experimental results are expressed as means ± S.E.M. A one-way analysis of variance was used for multiple comparisons (GraphPad Prism version 4.00 for Windows, San Diego, CA, USA). Dunnett's test was applied if there was a difference among the treated groups. A
In order to determine the preventive effect of INH2BP on the oxidative stress to myocardial cells, H9c2 cells pretreated with H2O2 and/or INH2BP were observed using the optical microscopy system. As a result, 85% of severe cell damage was identified in the group treated 700 μmol/L of H2O2 only.
However, about 80% and 60% of cell damage were observed at the concentration of 10 μmol/L and 50 μmol/L of INH2BP, respectively. And no cell damage was observed at 250 μmol/L of INH2BP (Fig. 1A).
In addition, XTT analyses showed that severe cell damage was induced at 700 μmol/L of H2O2 only- and at 10 μmol/L of INH2BP-treated groups. And at 50 μmol/L and 250 μmol /L of INH2BP-treated groups, the cell viabilities were increased by concentration-dependent manner (Fig. 1B).
As a result, it was confirmed that cell viability increased by concentration-dependent manner in the INH2BP (10~ 250 μmol/L)-treated groups.
To determine whether INH2BP inhibited of H2O2 (700 μmol/L)-induced apoptosis in H9c2 cells, Hoechst 33342 staining was performed.
As marked with yellow arrow in Fig. 2A, more than 60% of apoptotic bodies were observed in only H2O2-treated group.
In 10 and 50 μmol/L of INH2BP-treated groups, 50% and 60% of the apoptotic bodies were observed, respectively. However, almost no apoptotic bodies were observed in 250 μmol/L-treated groups.
In addition, by confirming of the ratio of Hoechst-positive cells to the total cells, the apoptosis was decreased in the concentration dependent manner by INH2BP (Fig. 2B).
It has been generally accepted that the excessive H2O2 induces the cell apoptosis by producing ROS.
Therefore, to determine whether INH2BP could remove intracellular ROS, H9c2 cells treated with H2O2 were stained by 10 μmol/L of DCF-DA and observed under a fluorescence microscopic system.
As a result of observation under the fluorescence microscope system, it was confirmed that the expression of ROS was increased as with the green fluorescence in the group treated with H2O2 only and reduced concentration-dependent manner in the INH2BP-treated group (Fig. 3A).
In addition, the same result was obtained in the measurement using a fluorescent spectrophotometer (Fig. 3B).
Several studies have suggested that PARP inhibitors can induce changes in intracellular ROS levels (Radnai et al., 2012; Kalai et al., 2009). Therefore, it was observed using a fluorescence image (Fig. 3A) and fluorescence assay (Fig. 3B) whether the PARP inhibitor, INH2BP, abolished H2O2-induced ROS in H9c2 cells. As a result, ROS production was increased in H9c2 cells exposed only to H2O2, When H2O2 and INH2B were treated together, it was confirmed that ROS production was reduced. Here, it was confirmed by using ESR whether INH2BP directly acts on intracellular ROS to eliminate it. As a result of ESR experiment, INH2BP did not directly scavenge DPPH, superoxide radical, and hydroxyl radical (Fig. 4, 5, 6). Therefore, INH2BP does not directly eliminate intracellular ROS, but activates a mechanism that eliminates intracellular ROS.
INH2BP has been reported to have various biological properties such as anti-cancer and anti-inflammatory (Endres et al., 1998; Szabo et al., 1997). However, the protective effect of cardiomyocytes has not yet been established. Car-diovascular disease is associated with increased production of hydrogen peroxide from damaged cells, which has been reported to be a major cause of pathogenesis as well as apoptosis of cardiomyocytes (Aikawa et al., 2000). Therefore, it has been previously suggested that suppressing cardiomyocyte apoptosis in response to excessive ROS is the main therapeutic goal (Park et al., 2014). Recently, experimental evidence of improved cardiac function has been implicated in INO-1001 and poly(ADP-ribose) polymerase (PARP) inhibitors, whereas ROS-induced PARP activation results in cell death (Pacher et al., 2006; Giansanti et al., 2010). For this reason, the inhibitory role of PARP has been implicated in the development of cardioprotective medicine. Since poly ADP-ribosylation is regulated by PARP, properties related to essential processes such as gene expression and DNA replication have been reported (Giansanti et al., 2010). Therefore, in this study, we aimed to establish whether PARP inhibition could modulate cardiomyocyte apoptosis in ROS conditions by the potential efficacy of INH2BP. Excessive ROS can induce heart enlargement or loss of function, and is the most common cause of cardiovascular disease. ROS triggers a specific mechanism that induces changes in the permeability of the mitochondrial membrane and disrupts the mitochondrial membrane. ROS can also be formed by a lack of ATP or an excess of viability Ca2+ ions (He et al., 2017; Sun et al., 2022). This ROS is phosphorylated or modified at the activation site of the protein, and not only regulates the protein related to signal transduction, but also inhibits the activity of the hydrolase to cause cell damage. In this study, as a result of light microscopy and XTT analysis, the cell viability of H9c2 cells subjected to oxidative stress by H2O2 was decreased due to severe cell damage, but the cell viability of H9c2 cells treated with INH2BP increased in a concentration-dependent manner, and INH2BP 250 μmol /L No cell damage was observed at the concentration (
None.
No potential conflict of interest relevant to this article was reported.